ISRCTN11565460
Can unscheduled inpatient length of stay and hospital costs be reduced using 'flash' glucose monitoring?
Interreg diabetes centre for personalised medicine - unscheduled care in diabetes - study 2: inpatient study
University of the Highlands and Islands·Phase 2·ISRCTN Registry·device·Device trial
Study focus
- Disease/Condition
- Diabetes mellitus
- Drug/Device/Intervention
- Flash Glucose Monitoring
- Study type
- Interventional
- Intervention type
- device
Sponsor & location
- Primary sponsor
- University of the Highlands and Islands
- Funder
- Interreg
- Location
- Ireland,United Kingdom
Timeline & enrollment
- Phase
- Phase 2
- Start date
- Oct 14, 2019
- End date
- Jan 31, 2022
- Enrollment
- 60 participants
Summary
Can unscheduled inpatient length of stay and hospital costs be reduced using ‘Flash’ glucose monitoring?
ICD-10 classifications
Diabetes mellitusUnspecified diabetes mellitusOther specified diabetes mellitusUnspecified diabetes mellitus without complicationsUnspecified diabetes mellitus with unspecified complications
Data source
- Registry
- ISRCTN Registry
- Trial ID
- ISRCTN11565460
- Type
- Device Trial
About this record
Access comprehensive clinical trial information for ISRCTN11565460 through Pure Global AI's free database. This Phase 2 trial is sponsored by University of the Highlands and Islands and is currently status unknown. The study focuses on Diabetes mellitus. Target enrollment is 60 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ISRCTN Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.